| Primary |
| Drug Use For Unknown Indication |
28.6% |
| Premedication |
21.4% |
| Crohn's Disease |
17.9% |
| Sinus Disorder |
10.7% |
| Analgesic Effect |
7.1% |
| Hypersensitivity |
3.6% |
| Injection Site Reaction |
3.6% |
| Pruritus |
3.6% |
| Rash |
3.6% |
|
| Syncope |
25.0% |
| Vision Blurred |
25.0% |
| Stillbirth |
12.5% |
| Yellow Skin |
12.5% |
| Anaemia |
6.3% |
| Pruritus |
6.3% |
| Sinus Disorder |
6.3% |
| Swelling Face |
6.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
45.7% |
| Product Used For Unknown Indication |
13.0% |
| Hepatitis C |
5.2% |
| Crohn's Disease |
4.8% |
| Headache |
3.7% |
| Ill-defined Disorder |
3.7% |
| Rash |
3.0% |
| Gastroenteritis |
2.6% |
| Pruritus |
2.6% |
| Analgesic Therapy |
2.2% |
| Anaphylactic Shock |
2.2% |
| Premedication |
1.9% |
| Analgesic Effect |
1.5% |
| Insomnia |
1.5% |
| Pain |
1.5% |
| Pruritus Generalised |
1.5% |
| Hypertension |
1.1% |
| Asthma |
0.7% |
| Desmoid Tumour |
0.7% |
| Hepatic Cirrhosis |
0.7% |
|
| Toxic Epidermal Necrolysis |
24.3% |
| Tremor |
13.5% |
| Vision Blurred |
10.8% |
| Trismus |
8.1% |
| Rhabdomyolysis |
5.4% |
| Syncope |
5.4% |
| Vomiting |
5.4% |
| Amnesia |
2.7% |
| Dry Mouth |
2.7% |
| Headache |
2.7% |
| Middle Insomnia |
2.7% |
| Myocardial Infarction |
2.7% |
| Pruritus |
2.7% |
| Snoring |
2.7% |
| Somnolence |
2.7% |
| Tongue Paralysis |
2.7% |
| Urticaria |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Drug Use For Unknown Indication |
18.0% |
| Premedication |
12.7% |
| Rheumatoid Arthritis |
6.1% |
| Breast Cancer |
4.8% |
| Hiv Infection |
4.5% |
| Prophylaxis |
4.1% |
| Pain |
3.5% |
| Myositis |
2.7% |
| Rash |
2.4% |
| Non-small Cell Lung Cancer |
2.3% |
| Osteoporosis |
2.1% |
| Haemorrhoidal Haemorrhage |
1.7% |
| Crohn's Disease |
1.6% |
| Dyspepsia |
1.6% |
| Ovarian Cancer |
1.6% |
| Pruritus |
1.6% |
| Nausea |
1.5% |
| Prophylaxis Of Nausea And Vomiting |
1.5% |
| Hypertension |
1.4% |
|
| Progressive Multifocal Leukoencephalopathy |
9.7% |
| Swelling Face |
9.0% |
| Vomiting |
9.0% |
| Wheezing |
7.6% |
| Pulmonary Embolism |
5.5% |
| Tachycardia |
5.5% |
| Nausea |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Lymphoedema |
4.1% |
| Paraesthesia |
4.1% |
| Pruritus |
4.1% |
| Rash |
4.1% |
| Visual Impairment |
4.1% |
| Circulatory Collapse |
3.4% |
| Mucosal Inflammation |
3.4% |
| Thrombocytopenia |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Viral Infection |
3.4% |
| Vision Blurred |
3.4% |
| Chest Discomfort |
2.8% |
|
